@FierceBiotech: Lilly delays its high-risk 'good' cholesterol trial with IMPROVE-IT in mind. Story | Follow @FierceBiotech
@JohnCFierce: ICYMI yesterday: Star scientist Peter Mueller gets $28M war chest to advance R&D at Pronutria. Article | Follow @JohnCFierce
@DamianFierce: Someone needs to talk to Mark Levin about this sweater situation. More | Follow @DamianFierce
> Sanofi's ($SNY) next CEO, widely rumored to be Bayer healthcare chief Olivier Brandicourt, will inherit a challenging situation upon taking the reins, as the drugmaker faces declining sales, pricing pressure and a tenuous relationship with French authorities. News
> More and more developers of gene therapies are warming up to the idea of annuity payments for their one-time treatments. More
> Dutch biotech BioNovion has paired up with Genmab to develop bispecific antibodies for immuno-oncology. Release
Medical Device News
@FierceMedDev: Lineagen reels in $19.8M in Series C round for autism genetic tests. Story | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: Vagus nerve stimulation, other forms of bioelectric medicine on cover of Scientific American. Item | Follow @VarunSaxena2
@EmilyWFierce: ICYMI: Boston Scientific hands over $600M to settle breach-of-contract Guidant suit with J&J. Article | Follow @EmilyWFierce
> GE recalls 10,000+ MRIs after FDA deems them potentially deadly, citing poor training. News
> Mayo Clinic joins $20.5M Series A reboot for next-gen sequencing startup Lifecode. Story
> FDA panel considering PMA application of spinal implant due to fractures. Article
Pharma News
@FiercePharma: ICYMI earlier: Pharma's top 10 deals of 2014. Feature | Follow @FiercePharma
@CarlyHFierce: Pharma wanted pricey orphan meds, and now it's got 'em in record numbers. Story | Follow @CarlyHFierce
> FDA grants Celgene's Revlimid new use as it moves toward $10B in sales. Story
> Regeneron's Eylea beats Roche's Lucentis in new head-to-head study. Article
> NICE, drugmakers reject analysis that price watchdog is too generous. Report
Vaccines News
> Advaxis nets $23M in financing for cancer vaccine development. More
> Protein Sciences halts Connecticut expansion in response to governor's use of rival flu shot. News
> Novavax's Ebola vaccine is in hot pursuit of GSK, Merck, J&J candidates. Story
> VaxInnate reaps $53M for flu jab trials on BARDA contract extension. Article
> Gates Foundation, WHO fund synthetic polio vaccine development. Report
Pharma Manufacturing News
> Taro recalls nearly 37,000 bottles of children's allergy relief syrup. Article
> WuXi inks deal to borrow $165M to support manufacturing growth. News
> InvaGen Pharma and AlphaMed Bottles building new plants on Long Island. Story
> Protein Sciences cancels expansion plans after governor gets flu shot from foreign competitor. Item
> India mulling plans to build bulk drug manufacturing capacity. Report